Rhabdomyosarcoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Rhabdomyosarcoma}} | {{Rhabdomyosarcoma}} | ||
{{CMG}};{{AE}} {{ | {{CMG}};{{AE}} {{S.M}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for Rhabdomyosarcoma. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for Rhabdomyosarcoma. | ||
==References== | ==References== | ||
Revision as of 19:31, 14 January 2019
|
Rhabdomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhabdomyosarcoma screening On the Web |
|
American Roentgen Ray Society Images of Rhabdomyosarcoma screening |
|
Risk calculators and risk factors for Rhabdomyosarcoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for Rhabdomyosarcoma.
Screening
There is insufficient evidence to recommend routine screening for Rhabdomyosarcoma.